恒瑞医药

- 600276

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011 
恒瑞医药(600276) 利润表
单位:万元
报表日期2021-03-312020-12-312020-09-302020-06-302020-03-31
一、营业总收入692,905.492,773,459.871,941,312.511,130,888.19552,701.53
营业收入692,905.492,773,459.871,941,312.511,130,888.19552,701.53
二、营业总成本516,135.002,128,204.631,453,340.86828,157.60397,284.59
营业成本91,039.84334,868.97238,454.98136,375.0274,089.90
营业税金及附加5,755.3125,695.9519,577.7611,641.195,807.21
销售费用233,015.62980,252.41690,734.32402,780.11192,655.70
管理费用62,903.68306,665.83188,485.34105,392.3849,513.60
财务费用-8,202.26-18,174.35-18,323.35-14,372.52-5,902.31
研发费用131,622.81498,895.82334,411.81186,341.4281,120.50
资产减值损失----------
公允价值变动收益-118.991,649.70-461.44-2,095.18-1,844.00
投资收益5,041.6234,142.4525,589.0719,282.188,167.05
其中:对联营企业和合营企业的投资收益----------
汇兑收益----------
三、营业利润180,051.07700,707.23519,328.92325,112.52161,215.91
加:营业外收入114.97106.90101.0473.2711.09
减:营业外支出2,890.0011,266.1415,295.939,172.092,972.35
其中:非流动资产处置损失----------
四、利润总额177,276.03689,548.00504,134.03316,013.69158,254.66
减:所得税费用27,672.4858,658.6979,859.6050,763.7227,667.79
五、净利润149,603.55630,889.31424,274.43265,249.97130,586.86
归属于母公司所有者的净利润149,654.76632,838.32425,859.21266,191.72131,542.59
少数股东损益-51.21-1,949.01-1,584.78-941.75-955.73
六、每股收益
基本每股收益(元/股)0.28001.19000.80000.50000.2900
稀释每股收益(元/股)0.28001.19000.80000.50000.2900
七、其他综合收益282.33-1,170.48-655.48441.96545.54
八、综合收益总额149,885.88629,718.83423,618.95265,691.93131,132.41
归属于母公司所有者的综合收益总额149,906.40631,705.91425,211.99266,607.81132,058.78
归属于少数股东的综合收益总额-20.51-1,987.08-1,593.03-915.88-926.38
下载全部历史数据到excel中 返回页顶